The role of PARP-2 in inhibiting prostate cancer
27 Jul 2020
The role of PARP-2 in inhibiting prostate cancer
OncoAlert and ecancer weekly roundup for July 19-25 2020
Epidemiology of gastric cancer
Pathology of diffuse gastric cancer with CDH1 mutation
Prophylactic gastrectomy in CDH1 mutation
Future perspective of CDH1 mutation in gastric and breast cancers
The European Cancer Prevention Organization
Laboratory analysis of CDH1 missense mutation
Prophylactic mastectomy and breast surveillance
The impact of COVID-19 on ALL patients in Spain
How should we manage patients with acute lymphoblastic leukaemia during COVID-19?
Why the ADAURA study is a big step forward for NSCLC